{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"921.9","upperLimit":"1102.6","value":"1008.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"190"}],"units":"Participants"}],"title":"Anti-HPV 6"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"722.2","upperLimit":"878.0","value":"796.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"190"}],"units":"Participants"}],"title":"Anti-HPV 11"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"4163.7","upperLimit":"5093.9","value":"4605.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"187"}],"units":"Participants"}],"title":"Anti-HPV 16"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1441.2","upperLimit":"1824.5","value":"1621.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"190"}],"units":"Participants"}],"title":"Anti-HPV 18"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1017.2","upperLimit":"1273.0","value":"1137.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"188"}],"units":"Participants"}],"title":"Anti-HPV 31"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"458.5","upperLimit":"562.4","value":"507.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"194"}],"units":"Participants"}],"title":"Anti-HPV 33"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"511.7","upperLimit":"655.6","value":"579.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"193"}],"units":"Participants"}],"title":"Anti-HPV 45"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"450.5","upperLimit":"556.7","value":"500.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"192"}],"units":"Participants"}],"title":"Anti-HPV 52"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"628.5","upperLimit":"783.7","value":"701.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"190"}],"units":"Participants"}],"title":"Anti-HPV 58"}],"denoms":[{"counts":[{"groupId":"OG000","value":"195"}],"units":"Participants"}],"description":"Anti-HPV Type 6, 11, 16, 18, 31, 33, 45, 52, and 58 antibodies are measured using a Competitive Luminex Immunoassay. Titers are reported in mMU/mL.","dispersionType":"95% Confidence Interval","groups":[{"description":"Participants received a single 0.5-mL intramuscular injection of the 9vHPV vaccine at Day 1, Month 2, and Month 6","id":"OG000","title":"9vHPV Vaccine"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"All allocated participants who were seronegative to the appropriate HPV type at Day 1, received all 3 vaccinations with the correct dose within acceptable day ranges, provided a serum sample within 21 to 49 days postdose 3, and had no protocol deviations that could interfere with the evaluation of participant's immune response to 9vHPV vaccination.","reportingStatus":"POSTED","timeFrame":"4 weeks postdose 3 (Month 7)","title":"Geometric Mean Titers of Antibodies to HPV 6, 11, 16, 18, 31, 33, 45, 52, and 58 at Month 7","type":"SECONDARY","unitOfMeasure":"mMU/mL"}